top of page
Abstract Structure

Transaction and News

Pfizer Opts In to LianBio Rights to Respiratory Syncytial Virus Therapeutic Candidate Sisunatovir in Mainland China, Hong Kong, Macau, and Singapore

December 27, 2022 at 9:44:59 PM

Merck and Kelun-Biotech Announce Exclusive License and Collaboration Agreement for Seven Investigational Antibody-drug Conjugate Candidates for the Treatment of Cancer

December 22, 2022 at 9:22:57 PM

Boston Scientific Announces Strategic Investment to Acquire Majority Stake of Acotec Scientific Holdings Limited

December 12, 2022 at 1:08:14 PM

China Pharma Holdings Acquires Dry Eye Disease Therapeutic Device Project

December 8, 2022 at 10:09:12 PM

Baozun Acquires Gap Greater China and Establishes Brand Management as a New Business Line

November 10, 2022 at 4:27:49 PM

China Resources Beer to Acquire Baijiu Maker for $1.7bn

October 28, 2022 at 2:13:47 PM

Abstract Structure
Collabrium Partners Logo

Company

Business

Legal

Location

Collabrium Partners & Co. Limited

9/F, Surson Commercial Building
140-142 Austin Road,
Tsim Sha Tsui, Kowloon,
Hong Kong

© 2019 Collabrium Partners & Co. Limited all rights reserved.

Mergers & Acquisitions
Strategic Advisory
Capital Restructuring
Private Placement
Special Committee
Independent Advice
Privacy Policy
Other Notices
Hong Kong
Beijing
Shanghai
Shenzhen
New York
London
Dubai
bottom of page